GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms

Diabetic Kidney Disease (DKD) is the leading cause of end stage renal disease (ESRD) worldwide. Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are now widely used in the treatment of patients with type 2 diabetes (T2D). A series of clinical and experimental studies demonstrated that GLP-1RAs h...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawanami, Daiji, Takashi, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338581/
https://www.ncbi.nlm.nih.gov/pubmed/32694999
http://dx.doi.org/10.3389/fphar.2020.00967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338581/
https://www.ncbi.nlm.nih.gov/pubmed/32694999
http://dx.doi.org/10.3389/fphar.2020.00967

Ejemplares similares